Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for stubborn hand eczema: drug targets inflammation from within

NCT ID NCT06283550

Completed Disease control Sponsor: Innovaderm Research Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a daily pill called abrocitinib in 82 adults with moderate to severe chronic hand eczema that did not get better with steroid creams. The goal was to see if the drug could reduce skin redness, scaling, and other symptoms. Researchers also checked for side effects and looked at skin changes using a gentle tape-stripping method.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HAND ECZEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HAND ECZEMA

Contacts and locations

Locations

  • INNO-6052 Site 11

    Montreal, Quebec, H2X 2V1, Canada

  • INNO-6052 Site 12

    Fredericton, New Brunswick, E3B 1G9, Canada

  • INNO-6052 Site 13

    Cobourg, Ontario, K9A 0Z4, Canada

  • INNO-6052 Site 15

    Pomorskie, Poland

  • INNO-6052 Site 16

    Warsaw, Poland

  • INNO-6052 Site 17

    Lodz, Poland

  • INNO-6052 Site 18

    Osielsko, Poland

  • INNO-6052 Site 19

    Krakow, Poland

  • INNO-6052 Site 20

    Szczecin, Poland

  • INNO-6052 Site 21

    Lublin, Poland

  • INNO-6052 Site 22

    Wroclaw, Poland

  • INNO-6052 Site 23

    Mikołów, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.